Author
There is an increasing drumbeat of support for an ethical and legal duty for physicians to reinterpret genetic test results.
Florida’s recent legislation highlights there is continued bipartisan interest in addressing concerns of genetic discrimination in insurance.
Direct-to-consumer genetic tests will soon be able to provide scores that estimate suicide risk, a prospect that raises ethical questions.
The health technology company Theranos once received enthusiastic media coverage for its promises of radical innovation in clinical laboratory testing and its eye-catching valuation of $9 billion. Now the company can’t seem to stop the…
By Katherine Kwong The news for blood testing company Theranos has gotten even worse since this blog’s last discussion of the company’s woes. Despite the company’s statements at the end of March that it would…
By Katherine Kwong The onslaught of bad news for Theranos, the start-up laboratory services company plagued with troubles since last October, continued this week with a new round of reports and press coverage. First, on…
By Katherine Kwong Our private health decisions may not be as private as we’d like to think. A recent article in the Wall Street Journal revealed a potentially uncomfortable situation: employers using health care analytics…
By Katherine Kwong Analysts from all over the political spectrum have long suggested that the Affordable Care Act’s provisions could lead to a reduction in employment numbers. New research suggests that contrary to these expectations,…
By Katherine Kwong Last week, the American Academy of Pediatrics publicly joined the group of advocates for federal regulations on e-cigarettes. The AAP urged the government to ban the sale of e-cigarettes to everyone under…
By Katherine Kwong The direct-to-consumer genetic testing company 23andMe was widely discussed in the news recently after it announced it would resume providing health information to customers. Less widely reported was another important announcement: for…
